Cargando…
Safety of Japanese encephalitis vaccines
Japanese encephalitis (JE) is an endemic disease dominantly in the Asia-Pacific region with mortality rate varying between 3% and 30%. Long-term neuropsychiatric sequelae developed in 30–50% of the survivors. There is no available antiviral therapy for JE. JE vaccines play a major role in preventing...
Autores principales: | Hu, Ya-Li, Lee, Ping-Ing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828133/ https://www.ncbi.nlm.nih.gov/pubmed/34613870 http://dx.doi.org/10.1080/21645515.2021.1969852 |
Ejemplares similares
-
Japanese encephalitis: The virus and vaccines
por: Yun, Sang-Im, et al.
Publicado: (2014) -
The changing epidemiology of Japanese encephalitis and New data: the implications for New recommendations for Japanese encephalitis vaccine
por: Connor, Bradley, et al.
Publicado: (2017) -
Japanese Encephalitis Vaccines
por: Satchidanandam, Vijaya
Publicado: (2020) -
Changes in age-specific seroprevalence of Japanese encephalitis virus and impact of Japanese encephalitis vaccine in Korea
por: Kwak, Byung Ok, et al.
Publicado: (2021) -
Japanese Encephalitis Virus: An Update on the Potential Antivirals and Vaccines
por: Srivastava, Kumar Saurabh, et al.
Publicado: (2023)